Molecular Templates Inc
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas. Show More...
-
Website https://www.mtem.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.00 USD
-
Last Updated 21-04-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -6.16 -6.16 -14.41 -5.39 -5.39 5.94 -3.74 -2.11 -1.02 -1.86 -2.17 Dividends USD Payout Ratio % * Shares Mil 3.0 4.0 5.0 5.0 6.0 7.0 7.0 11.0 30.0 38.0 40.0 Book Value Per Share * USD 1.61 2.12 -2.7 -3.25 -3.67 -4.76 3.52 3.27 2.89 1.16 1.83 Free Cash Flow Per Share * USD -7.35 -6.44 5.97 4.57 -5.0 -6.56 -4.13 -1.86 -1.4 -0.72 Return on Assets % -57.58 -132.78 -127.08 -29.35 -25.02 71.8 -61.82 -42.03 -26.27 -44.17 -56.59 Financial Leverage (Average) 3.28 5.0 1.31 1.22 1.17 1.39 1.69 1.92 Return on Equity % -135.38 -544.3 519.53 -79.34 -49.6 -33.99 -68.08 -94.8 Return on Invested Capital % -135.38 -544.3 519.53 -79.34 -44.74 -32.92 -63.52 -82.91 Interest Coverage -26.13 -29.59 -52.48 -62.02 Current Ratio 4.45 2.39 5.02 3.18 2.57 4.91 9.24 5.79 3.23 3.91 2.83 Quick Ratio 4.18 2.36 4.96 3.1 2.54 4.67 9.0 5.64 3.02 3.7 2.64 Debt/Equity 0.010 0.03 0.14 0.17